135 studies found for:    ANGIOTENSIN I-CONVERTING ENZYME
Show Display Options
Rank Status Study
1 Recruiting Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Angioedema
Condition: Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Interventions: Drug: Icatibant;   Drug: Placebo
2 Recruiting ACE-Inhibitor Effects on Total Hip and Knee Arthroplasty Patients
Conditions: Adverse Effects of Angiotensin-converting-enzyme Inhibitors;   Hypotension
Interventions: Other: Cessation group;   Other: Continuation group
3 Completed Study of the Interaction Between the Cells Lining Blood Vessels and Angiotensin-Converting Enzyme
Conditions: Atherosclerosis;   Coronary Disease
Intervention:
4 Completed
Has Results
The RAS, Fibrinolysis and Cardiopulmonary Bypass
Conditions: Coronary Artery Disease;   Angiotensin Converting Enzyme;   Angiotensin Receptor Blockers;   Cardiopulmonary Bypass;   Fibrinolysis;   Inflammation
Interventions: Drug: Placebo;   Drug: Ramipril;   Drug: Candesartan
5 Completed Angiotensin Converting Enzyme Inhibitors and Periprocedural Myocardial Infarction
Conditions: Metabolic Syndrome;   Coronary Artery Disease
Intervention:
6 Completed ACE Gene Polymorphism and ARDS Outcome
Condition: Adult Respiratory Distress Syndrome
Intervention:
7 Completed Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization
Condition: Kidney Failure
Intervention: Drug: Hold ACEI or ARB
8 Terminated Angiotensin-Converting Enzyme Polymorphism and Acute Renal Failure (ECAREA)
Conditions: Kidney Failure, Acute;   Critical Illness
Intervention: Procedure: Blood sampling for PCR
9 Not yet recruiting Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
Conditions: Psoriasis;   Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Gliclazide;   Drug: Sitagliptin matched placebo;   Drug: Gliclazide matched placebo capsule
10 Terminated Angiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in Children
Condition: Sickle Cell Disease
Interventions: Drug: Enalapril;   Drug: Placebo
11 Not yet recruiting The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome
Condition: Polycystic Ovary Syndrome
Interventions: Drug: Sitagliptin;   Drug: Placebo
12 Unknown  The Acute Effects of the Angiotensin-Converting Enzyme Inhibitor Enalaprilat on Flow Distribution
Conditions: Hypertension;   Congestive Cardiomyopathy
Intervention: Drug: Enalaprilat
13 Unknown  Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema
Condition: Angioedema
Intervention: Drug: ecallantide - Kallikrein inhibitor that blocks the production of bradykinin
14 Recruiting Outcomes of Angiotensin Converting Enzyme Inhibitor Management Strategies Prior to Coronary Artery Bypass
Condition: Coronary Artery Disease
Interventions: Drug: ACE/ARB continuation;   Drug: ACE/ARB withdrawal
15 Not yet recruiting Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure
Conditions: Type 2 Diabetes Mellitus;   Hypertension
Interventions: Drug: Placebo;   Drug: Sitagliptin;   Drug: Aprepitant;   Other: Mixed Meal Test (MMT)
16 Unknown  Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3
Conditions: Chronic Kidney Insufficiency;   Angiotensin-Converting Enzyme Inhibitors;   Angiotensin II Type 1 Receptor Blockers;   Proteinuria
Intervention: Drug: Fosinopril and Losartan
17 Terminated Rhubarb and Angiotensin Converting Enzyme Inhibitor
Condition: Diabetic Kidney Disease
Interventions: Dietary Supplement: rhubarb extract;   Dietary Supplement: placebo
18 Completed Effects of a Resistance Training Period on Blood Pressure of Hypertensive Elderlies: Influence of the Polymorphism of the Angiotensin Converting Enzyme
Condition: Hypertension
Intervention: Behavioral: Resistance training
19 Completed Angiotensin Converting Enzyme Inhibitors in Marfan Syndrome
Condition: Marfan Syndrome
Intervention: Drug: Coversyl (perindopril)
20 Completed Angiotensin Converting Enzyme Inhibitors During Cardiopulmonary Bypass in Infants and Children
Condition: Congenital Heart Disease
Interventions: Drug: Angiotensin Converting Enzyme Inhibitor;   Other: No ACE inhibitor

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years